{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:05:12Z","timestamp":1788285912855,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"ASIT Biotech S.A."},{"name":"Institute of Medical Statistics, Informatics and Epidemiology"},{"name":"ASIT Biotech S.A."},{"name":"Biotech tools"},{"name":"ALK-Abell\u00f3"},{"name":"Anergis"},{"name":"Adiga"},{"name":"Biomay"},{"name":"Allergy Therapeutics"},{"name":"Med Update GmbH"},{"DOI":"10.13039\/501100000354","name":"Food Standards Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003441","name":"Ghent University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003441","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ASIT Biotech S.A"},{"name":"Immune Tolerance Network"},{"name":"ASIT Biotech S.A."},{"name":"ALK-Abell\u00f3"},{"DOI":"10.13039\/100009857","name":"Regeneron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jaci.2019.02.023","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T20:02:57Z","timestamp":1551729777000},"page":"738-749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A\u00a0randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"144","author":[{"given":"Hanisah","family":"Sharif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iesha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Kouser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"M\u00f6sges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Alix","family":"Bonny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Karamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca V.","family":"Parkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bovy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Robb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Katotomichelakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabri\u00eble","family":"Holtappels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Derycke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"von Frenckell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Wathelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Duchateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Legon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Pirotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Shamji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2019.02.023_bib1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0091-6749(98)70271-4","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. A\u00a0WHO position paper","volume":"102","author":"Bousquet","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jaci.2011.02.016","article-title":"Recombinant allergens: what does the future hold?","volume":"127","author":"Valenta","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199908123410702","article-title":"Long-term clinical efficacy of grass-pollen immunotherapy","volume":"341","author":"Durham","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.02.023_bib4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jaci.2010.12.1080","article-title":"Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies","volume":"127","author":"James","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jama.2016.21040","article-title":"Effect of 2 years of treatment with sublingual grass pollen immunotherapy on nasal response to allergen challenge at 3 years among patients with moderate to severe seasonal allergic rhinitis: the GRASS randomized clinical trial","volume":"317","author":"Scadding","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2019.02.023_bib6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1183\/09031936.04.00013904","article-title":"Prevalence and rate of diagnosis of allergic rhinitis in Europe","volume":"24","author":"Bauchau","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2019.02.023_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2222.2011.03891.x","article-title":"Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America","volume":"42","author":"Katelaris","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2019.02.023_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2017.09.013","article-title":"Lolium perenne peptides for treatment of grass pollen allergy: a randomized, double-blind, placebo-controlled clinical trial","volume":"141","author":"Shamji","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/all.13392","article-title":"Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients","volume":"73","author":"M\u00f6sges","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.02.023_bib10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/all.13358","article-title":"A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy","volume":"73","author":"M\u00f6sges","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.02.023_bib11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0091-6749(94)90176-7","article-title":"Complementary DNA cloning of the major allergen phl p I from timothy grass (Phleum pratense); recombinant phl p I inhibits IgE binding to group I allergens from eight different grass species","volume":"94","author":"Laffer","year":"1994","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl\u00a05","key":"10.1016\/j.jaci.2019.02.023_bib12","doi-asserted-by":"crossref","first-page":"S292","DOI":"10.1513\/AnnalsATS.201402-090AW","article-title":"Mechanisms of peptide immunotherapy in allergic airways disease","volume":"11","author":"Larch\u00e9","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaci.2019.02.023_bib13","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/all.13433","article-title":"Short-course of grass allergen peptides immunotherapy over three weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with\/without asthma: a randomized, multicenter, double-blind, placebo-controlled trial","volume":"73","author":"M\u00f6sges","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.02.023_bib14","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.010","article-title":"Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers","volume":"140","author":"Shamji","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jaci.2011.08.034","article-title":"Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy","volume":"129","author":"Wambre","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaci.2017.04.032","article-title":"Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells","volume":"141","author":"Schulten","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib17","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jaci.2014.09.049","article-title":"Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy response","volume":"135","author":"Shamji","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jim.2006.09.004","article-title":"The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses","volume":"317","author":"Shamji","year":"2006","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaci.2019.02.023_bib19","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/all.12878","article-title":"T follicular helper (Tfh) cells in normal immune responses and in allergic disorders","volume":"71","author":"Varricchi","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.02.023_bib20","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/cea.12750","article-title":"Follicular helper T cells are responsible for IgE responses to Der p 1 following house dust mite sensitization in mice","volume":"46","author":"Noble","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2019.02.023_bib21","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/blood-2008-02-142745","article-title":"STAT3 is required for IL-21 induced secretion of IgE from human naive B cells","volume":"112","author":"Avery","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2019.02.023_bib22","doi-asserted-by":"crossref","first-page":"13439","DOI":"10.1073\/pnas.0901965106","article-title":"Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.02.023_bib23","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ni.2084","article-title":"Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation","volume":"12","author":"Beyer","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib24","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.immuni.2014.12.005","article-title":"The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells","volume":"41","author":"Sage","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.02.023_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1067\/mai.2003.1683","article-title":"Patterns of pollen cross-allergenicity","volume":"112","author":"Weber","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1398-9995.2011.02745.x","article-title":"Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy","volume":"67","author":"Shamji","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.02.023_bib27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib28","doi-asserted-by":"crossref","first-page":"176ra32","DOI":"10.1126\/scitranslmed.3005191","article-title":"Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination","volume":"5","author":"Bentebibel","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2019.02.023_bib29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.immuni.2013.09.007","article-title":"Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure","volume":"39","author":"He","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.02.023_bib30","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.4049\/jimmunol.181.3.1767","article-title":"IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4","volume":"181","author":"Avery","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib31","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0091-6749(96)70205-1","article-title":"Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T\u00a0lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma","volume":"97","author":"Durham","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2332\/allergolint.13-RAI-0650","article-title":"Allergen immunotherapy and tolerance","volume":"62","author":"Matsuoka","year":"2013","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2019.02.023_bib33","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1073\/pnas.0509484103","article-title":"Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development","volume":"103","author":"Gavin","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.02.023_bib34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ni0417-474d","article-title":"Erratum: Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment","volume":"18","author":"Kitagawa","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib35","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.2425","article-title":"Foxp3(+) follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2019.02.023_bib36","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1172\/JCI76861","article-title":"Circulating T follicular regulatory and helper cells have memory-like properties","volume":"124","author":"Sage","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.02.023_bib37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2019.02.023_bib38","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jaci.2018.06.041","article-title":"Role of Interleukin-35 in sublingual allergy immunotherapy","volume":"143","author":"Shamji","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2013.03.013","article-title":"Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy","volume":"132","author":"Kiel","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib40","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/cea.12488","article-title":"Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects","volume":"45","author":"Couroux","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2019.02.023_bib41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2249.2010.04106.x","article-title":"Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A\u00a0in children","volume":"160","author":"Rosewich","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2019.02.023_bib42","doi-asserted-by":"crossref","first-page":"17908","DOI":"10.1073\/pnas.0803725105","article-title":"Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial","volume":"105","author":"Senti","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2019.02.023_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/all.13240","article-title":"Ultra-short-course booster is effective in recurrent grass pollen-induced allergic rhinoconjunctivitis","volume":"73","author":"Pfaar","year":"2018","journal-title":"Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919302878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919302878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:18:56Z","timestamp":1758791936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674919302878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0091674919302878"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2019.02.023","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A\u00a0randomized, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}